Date
Cost
Available to
Continuing Professional Development
3 RACGP CPD Activity points available
The aim of this session is to provide information on recent changes in acceptance criteria for colposcopy and the latest evidence for ovarian cancer screening.
This webinar will discuss:
- Ovarian cancer screening: Has there been any progress?
- Updates on referral criteria for colposcopy
Ovarian cancer screening: Has there been any progress?
Ovarian cancer is the fifth most common cause of cancer death in women in Australia. It is more difficult to diagnose in early stages largely because symptoms can be vague and similar to those of other common illnesses. This webinar will discuss the latest evidence on screening for ovarian cancer and management of women at risk.
Speaker: Assoc Prof Orla McNally
Associate Professor Orla McNally, Consultant Gynaecologist Oncologist and Director of Oncology/Dysplasia clinic, Royal Women’s Hospital.
Updates on referral criteria for colposcopy
National Cervical Screening Program’s (NCSP) clinical guidelines for the clinical management of women at intermediate risk have changed in February 2021. Dr Wrede will discuss changes and management of women with an intermediate risk result on their Cervical Screening Test.
Speaker: Dr David Wrede
Dr David Wrede, Consultant Gynaecologist and Lead for Dysplasia, Royal Women’s Hospital.
Learning outcomes:
By the end of this session you will be able to:
- Refer to the latest evidence on screening for ovarian cancer and management of women at risk
- Assess and manage of women who have intermediate risk results on their cervical screening test
- Identify the changes to the National Cervical Screening Program's Clinical Guidelines pathway for women at intermediate risk